By region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest market share of over 36.04% in 2023, owing to the increasing investment in research and development activities, advanced healthcare infrastructure, and presence of established drug manufacturers in North America.
Further, the presence of renowned market players who are actively involved in fulfilling consumer demand in the region is burgeoning the region’s market growth. For instance, Cyanotech Corporation (US) sells BioAstin through Nutrex Hawaii as a packaged consumer product to natural product distributors, retailers, and online channels, as well as directly to consumers.
It is also supplied as a raw ingredient to dietary supplements, health foods, and cosmetic manufacturers in the form of liquid lipids. BioAstin gelcaps are available in bulk to international distributors. Thus, the presence of such market players, who are expanding their presence through distributors and online channels, is fostering the region’s growth.
Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia.
FIGURE 3: BLUE BIOTECHNOLOGY MARKET, BY REGION, 2023 & 2032 (USD BILLION)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
The Europe blue biotechnology market shows significant growth during the forecast year, i.e., 2024–2032, owing to the presence of huge start-ups associated with blue biotechnology. For instance, Calouste Gulbenkian and the Oceano Azul Foundations, both headquartered in Portugal, received more than 120 projects from over 30 countries until September 2020 associated with blue biotechnology.
Further, in September 2020, Blue Bio Value (Portugal) launched its acceleration program for startups related to the blue bioeconomy with 15 projects from eight different countries in Europe: Portugal, Spain, France, Ireland, Italy, The Netherlands, and the United Kingdom. The Germany blue biotechnology market held the largest market share in 2023, and the UK blue biotechnology market is the fastest-growing market in the Europe region.
The Asia-Pacific blue biotechnology market is the fastest-growing region during the forecast period owing to high demand for marine-derived products in various industries including agriculture, pharmaceuticals, cosmetics, among others. Furthermore, advances in biotechnological tools and techniques, such as genomics, proteomics, and metabolomics, have made it easier to investigate and exploit marine resources which is burgeoning the market growth.
These technologies allow researchers to more efficiently identify, isolate, and produce valuable compounds from marine organisms. Moreover, China blue biotechnology market held the largest market share in 2023 and India blue biotechnology market is the fastest growing market in the Asia-Pacific region.